The objective of this study is to investigate the relationship between radiomic signatures and the p53 phenotype within the framework of IDH mutations, thereby advancing the application of radiomics in clinical decision‐making for glioma molecular classification. The gene discussed is TP53; the disease is central nervous system cancer.